Notably, many known kinase protein targets that OPPTI identified, including ERBB2 in BRCA, CDK6 in HCC and BRCA, and EGFR in LUAD and CRC, were not found to show differential expression in tumor. This evidence concerns the gene ERBB2 and hepatocellular carcinoma.